BLOG

Novel drug regimen can improve stem cell transplantation outcomes – Medical Xpress

Novel drug regimen can improve stem cell transplantation outcomesMedical XpressAdding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem–cell transplants from mismatched and unrelated donors, according to researchers from Dana-Farber …Stem Cell Transplants can be improved by New Drug RegimenTopNews United States all 3 news articles …read … Continue reading

2013-12-08 NEWS

Novel drug regimen can improve stem cell transplantation outcomes – EurekAlert (press release)

Novel drug regimen can improve stem cell transplantation outcomesEurekAlert (press release)NEW ORLEANS— Adding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem–cell transplants from mismatched and unrelated donors, according to researchers … and more …read more   &nbs… Continue reading

2013-12-08 NEWS